当前位置:
X-MOL 学术
›
Microb. Drug Resist.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Efficacy of the Xpert MTB/RIF Assay in Multidrug-Resistant Tuberculosis.
Microbial Drug Resistance ( IF 2.3 ) Pub Date : 2020-07-31 , DOI: 10.1089/mdr.2019.0326 Nurlan S Tabriz 1 , Kuliya Skak 1 , Lazzat T Kassayeva 2 , Bauyrzhan K Omarkulov 3 , Marina A Grigolashvili 4
Microbial Drug Resistance ( IF 2.3 ) Pub Date : 2020-07-31 , DOI: 10.1089/mdr.2019.0326 Nurlan S Tabriz 1 , Kuliya Skak 1 , Lazzat T Kassayeva 2 , Bauyrzhan K Omarkulov 3 , Marina A Grigolashvili 4
Affiliation
Background: Half a million new cases of multidrug-resistant tuberculosis (MDR-TB) are registered annually, and therefore, the issue of the development of new fast and reliable methods for diagnosis of tuberculosis (TB) remains urgent in modern phthisiology.
中文翻译:
Xpert MTB / RIF分析在耐多药结核病中的功效。
背景:每年有五百万例新的耐多药结核病(MDR-TB)病例登记,因此,在现代药理学中,迫切需要开发新的快速可靠的诊断结核病(TB)方法的问题。
更新日期:2020-08-08
中文翻译:
Xpert MTB / RIF分析在耐多药结核病中的功效。
背景:每年有五百万例新的耐多药结核病(MDR-TB)病例登记,因此,在现代药理学中,迫切需要开发新的快速可靠的诊断结核病(TB)方法的问题。